Disruptions in antigen processing and presentation machinery on sarcoma.

Area of Science:

• Oncology
• Immunology
• Molecular Biology

Background:

• The antigen processing machinery (APM) is crucial for presenting tumor antigens to the immune system.
• Defects in APM can lead to cancer immune evasion and poor outcomes.
• APM status in sarcomas is poorly understood, hindering immunotherapy development.

Purpose of the Study:

• To investigate the status of APM components in various sarcoma types.
• To determine the prognostic significance of APM defects in sarcomas.
• To identify potential targets for sarcoma immunotherapy.

Main Methods:

• Analysis of 126 sarcoma patients across 8 histotypes using tissue microarrays.
• Immunohistochemical assessment of APM protein expression in 11 distinct tumor areas per case.
• Application of Bayesian networks to analyze APM alterations and clinical data.

Main Results:

• All sarcomas exhibited APM defects, with varying prevalence across histotypes and tumor regions.
• Commonly altered APM components included HLA Class I subunit β2-microglobulin, HLA Class I subunit α (HC10), and MHC I transporting unit TAP2.
• Loss of APM components was a significant predictor of distant metastasis (LMS, DDLPS) and overall survival (LMS).

Conclusions:

• Sarcomas display widespread APM defects, differing by histotype and tumor microenvironment.
• Specific APM alterations are linked to prognosis, particularly in leiomyosarcoma (LMS) and dedifferentiated liposarcoma (DDLPS).
• Understanding these molecular mechanisms can inform personalized therapeutic strategies for sarcoma patients.